Skip to main content
HR 8641 117th Congress House

Orphan Drug COVID–19 Mitigation Act of 2022

Official title: To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic for the development of orphan drugs, and for other purposes.

Introduced: August 2, 2022 Introduced by: Gottheimer, Josh Democratic · New Jersey See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 2, 2022
Referred to the House Committee on Energy and Commerce.
Aug 2, 2022
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action August 2, 2022

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Orphan Drug COVID-19 Mitigation Act of 2022

This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 1 Republican 1
Schrader, Kurt
· Oct 21, 2022
 R
Bacon, Don
Nebraska · Aug 2, 2022
 D
Dean, Madeleine
Pennsylvania · Aug 2, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 8641: Orphan Drug COVID–19 Mitigation Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-8641/
MLA
"H.R. 8641: Orphan Drug COVID–19 Mitigation Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-8641/.
Bluebook (legal)
H.R. 8641, 117th Cong. (2026), https://openamerica.io/bill/117-HR-8641/.
Markdown link
[H.R. 8641: Orphan Drug COVID–19 Mitigation Act of 2022](https://openamerica.io/bill/117-HR-8641/)
Report a problem